Jeff Yass’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,700
| Closed | -$188K | – | 12921 |
|
|
2024
Q4 | $188K | Sell |
30,700
-15,800
| -34% | -$188K | ﹤0.01% | 10797 |
|
|
2024
Q3 | $769K | Buy |
46,500
+33,900
| +269% | +$371K | ﹤0.01% | 7426 |
|
|
2024
Q2 | $86.6K | Buy |
+12,600
| New | +$108K | ﹤0.01% | 11117 |
|
|
2023
Q3 | – | Sell |
-16,100
| Closed | -$149K | – | 12436 |
|
|
2023
Q2 | $149K | Buy |
+16,100
| New | +$180K | ﹤0.01% | 10590 |
|
|
2022
Q2 | – | Sell |
-84,700
| Closed | -$2.26M | – | 13356 |
|
|
2022
Q1 | $2.26M | Buy |
84,700
+60,700
| +253% | +$1.13M | ﹤0.01% | 5194 |
|
|
2021
Q4 | $704K | Buy |
24,000
+19,400
| +422% | +$964K | ﹤0.01% | 8240 |
|
|
2021
Q3 | $302K | Buy |
4,600
+1,400
| +44% | +$107K | ﹤0.01% | 10588 |
|
|
2021
Q2 | $266K | Sell |
3,200
-17,100
| -84% | -$1.27M | ﹤0.01% | 11032 |
|
|
2021
Q1 | $1.56M | Sell |
20,300
-10,600
| -34% | -$965K | ﹤0.01% | 6536 |
|
|
2020
Q4 | $2.73M | Sell |
30,900
-124,600
| -80% | -$8.76M | ﹤0.01% | 4470 |
|
|
2020
Q3 | $11.5M | Buy |
+155,500
| New | +$9.2M | ﹤0.01% | 2019 |
|
Other funds holding IGMS
Jeff Yass's IGMS Position: Q3 2025 in Review
Jeff Yass sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 80,311 shares — an estimated $89.9K sold.
Jeff Yass first reported a position in IGMS in Q3 2020 and held it in 13 quarters. The position peaked at $2.17M in Q3 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Jeff Yass reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Jeff Yass sold 80,311 IGM Biosciences shares in Q3 2025, an estimated $89.9K.
- Jeff Yass first reported a position in IGM Biosciences in Q3 2020 and held it in 13 quarters.
- Jeff Yass's IGM Biosciences position peaked at $2.17M in Q3 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.